Treatment(s) now being considered-Cytoreductive surgery Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Cytoreductive surgery Posts on Medivizor

Does adding chemotherapy to cytoreductive surgery improve the outcome of patients with peritoneal metastases from colorectal cancer?

Does adding chemotherapy to cytoreductive surgery improve the outcome of patients with peritoneal metastases from colorectal cancer?

Posted by on Apr 11, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the benefit of adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery (CS) for the treatment of colorectal cancer (CRC) that has spread to the peritoneum (the lining of the abdomen that covers all abdominal organs). The study found that HIPEC added to CS did not improve the outcomes of...

Read More

Physical exercise after surgery is associated with improved recovery from colorectal cancer

Physical exercise after surgery is associated with improved recovery from colorectal cancer

Posted by on Mar 4, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of exercise on recovery from colorectal cancer surgery. Researchers reported that exercise was associated with an improved recovery. Some background Recovery after surgery is only complete when the patient is able to return to normal day-to-day life. Not all colorectal cancer patients recover their...

Read More

Comparing the safety of surgery options for patients with peritoneal metastasis

Posted by on Jan 11, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the safety of hyperthermic intraperitoneal chemotherapy (HIPEC) and surgery in colon cancer patients with peritoneal metastasis (PM). Researchers reported that HIPEC and surgery was associated with an increased risk of complications. Some background When colon cancer spreads to the abdominal lining (known as...

Read More

Comparison of two treatments for colorectal cancer that has spread to the peritoneum

Comparison of two treatments for colorectal cancer that has spread to the peritoneum

Posted by on Apr 27, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared two treatments for peritoneal metastasis in colorectal cancer (cancer that has spread to the lining of the abdomen).  Some background Peritoneal metastasis is a serious complication of colorectal cancer. It is not usually treatable with standard chemotherapy, which is injected into veins or given by...

Read More

Colorectal cancer that has spread to the peritoneum: can muscle mass predict treatment complications?

Colorectal cancer that has spread to the peritoneum: can muscle mass predict treatment complications?

Posted by on Mar 23, 2015 in Colorectal cancer | 0 comments

In a nutshell This study examined whether skeletal muscle mass could be used to predict complications in colorectal cancer patients undergoing treatment for cancer that has spread to the peritoneum (the lining of the abdomen). Some background Metastatic colorectal cancer indicates that the cancer has spread from the colon or rectum to another...

Read More

Comparing two chemotherapy drugs for cancer that has spread to the peritoneum

Posted by on Mar 23, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared the outcome of patients with colorectal or appendix cancer that had spread to the peritoneum (the lining of the abdominal cavity). Some background Peritoneal metastasis indicates that the initial cancer has spread to the peritoneum. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) is...

Read More

Smoking and surgery

Smoking and surgery

Posted by on Sep 25, 2013 in Colorectal cancer | 0 comments

In a nutshell This study examined the impact of smoking on the results of colorectal surgery. Some background Surgery for the removal of colorectal cancer, like any surgical intervention, carries the risk of serious complications. Smoking has been found to be a risk factor for complications in several types of major surgery. This is presumably due...

Read More

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as primary treatment for patients with metastatic colorectal cancer

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as primary treatment for patients with metastatic colorectal cancer

Posted by on Mar 13, 2013 in Colorectal cancer | 0 comments

In a nutshell The present clinical trial compared two chemotherapy regimens as first-line treatment for patients with metastatic colorectal cancer (mCRC): XELIRI-bevacizumav versus FOLFIRI-bevacizumab. Some background Approximately one quarter of patients with colorectal cancer (cancer in the large intestine) have metastases,...

Read More

Comparison of two surgical techniques for the treatment of pseudomyxoma peritonei

Comparison of two surgical techniques for the treatment of pseudomyxoma peritonei

Posted by on Mar 4, 2013 in Colorectal cancer | 1 comment

In a nutshell The present study compared the efficacy of two surgical techniques to treat pseudomyxoma peritonei (PMP): debulking and cytoreduction. Cytoreductive surgery achieved better surgical results and yielded higher 3- and 5-year survival rates, compared with debulking. Some background PMP is a rare condition caused by the production of...

Read More